[Experiences with "Schedules for Clinical Assessment in Neuropsychiatry (SCAN)" within the scope of a multicenter field study].
The "Schedules for Clinical Assessment in Neuropsychiatry" (SCAN), a comprehensive set of clinical assessment instruments were developed by the World Health Organization (WHO) and the London Institute of Psychiatry. A central aim is to provide clinicians and researchers with a standardized interview for ICD-10 diagnoses. Core instrument of SCAN is the 10th version of the "Present State Examination" (PSE) which has proved to be one of the most helpful psychopathological assessment instruments. PSE-10 covers a wide range of non-psychotic as well as of psychotic symptoms and includes special modules for ICD-10 and DSM-IIIR diagnoses, e.g. alcohol and drug abuse, sleeping and eating disorders. A computer program (CATEGO-V) is also developed for standardized scoring and diagnostics. The paper introduces SCAN by describing its structure and applicability. Different rating periods and scales are explained, and PSE-10 is contrasted with PSE-9 in a whole. SCAN experiences within a reliability study are reported, completed by a critical evaluation of the most recent version of the SCAN system.
Maurer
K
K
Zentralinstitut für Seelische Gesundheit, WHO-Kollaborationszentrum für Forschung, Mannheim.
Hillig
A
A
Freyberger
H J
HJ
Velthaus
S
S
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000175:diagnosis / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule / Q000706:statistics & numerical data*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000175:diagnosis* / Q000523:psychology; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011594:Psychometrics; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000523:psychology; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000523:psychology
Erfahrungen mit den "Schedules for Clinical Assessment in Neuropsychiatry (SCAN)" im Rahmen einer multizentrischen Feldstudie.